Replies to post #349488 on Innovation Pharmaceuticals Inc (IPIX)

[JohnLocke101]

I find it highly improbable, that the company in consult with the fda, via a pre-ind meeting, would design a P2 study for the treating of COVID-19 where the end data results in the inability to convey any statistical significance. That is what you’re suggesting, right? Sounds like serious malpractice.

[DoubleJ23]

It's probably not important

Finally something we can all agree upon. Mind if I borrow that? TIA

[BonelessCat]

I guess it's best just to wait and see.

Yes.